EUVIMEDEUVIMED entdecken
Crossref

Post‐semaglutide weight regain in females with obesity: Associations with gut microbiota, bile acid metabolism, and central nervous system

Ning Wang, Haonan Guo, Lin Song, Jingyue Wang, Shuyuan Hu, Mingxi Wang, Duowen Zhang, Yingyu Jing, Yifan Zhang, Mengjun Wang, Ting Wang, Bo Sun iD

Diabetes, Obesity and Metabolism · 2026-05 · 28 (5) · 3903-3916

DOI: 10.1111/dom.70571 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 18.02.2026. Verfasst von Ning Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. Hauptthemen laut MEDLINE: Obesity, Weight Gain, Bile Acids and Salts, Gastrointestinal Microbiome. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Natural Science Foundation of China, IIT Clinical Research Fund of The Second Affiliated Hospital of Xi'an Jiaotong University, Natural Science Basic Research Program of Shaanxi Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

To investigate the metabolic mechanisms underlying weight regain (WR) after semaglutide withdrawal in females with obesity, focusing on gut microbiota, bile acid metabolism, and central nervous system regulation. Materials and methods In a prospective, single‐arm interventional study, 28 women with obesity finished 36‐week semaglutide treatment (2.4 mg/week) followed by 12‐week withdrawal. Parallel animal studies used HFD‐fed female rats with 4‐week semaglutide intervention and 4‐week withdrawal. Measurements included body weight, metabolic parameters, gut microbiota composition, bile acid profiles, and hypothalamic gene expression.

Results

During treatment, patients achieved significant weight loss (−16.9 ± 4.8 kg), but 71.4% exhibited WR (+5.1 ± 1.6 kg) post‐withdrawal, with 78.5% reporting appetite rebound (≥30% increase in VAS score and a sustained ≥300 kcal/day rise). Animal studies showed post‐withdrawal gut microbiota dysbiosis (increased Firmicutes / Bacteroidota ratio, reduced Clostridium sensu stricto 1 ), decreased ursodeoxycholic acid levels, and downregulated hypothalamic TGR5 expression. Hypothalamic orexigenic signaling (AgRP/NPY) rebounded while anorexigenic pathways (POMC/MC4R) attenuated. Improvements in hepatic and adipose lipid metabolism partially persisted through maintained AMPK/SIRT1 activation and AKT/mTOR suppression.

Conclusions

The recurrence of WR and increased appetite after semaglutide withdrawal coincided with reversals in gut microbiota and related metabolic profiles. This pattern of changes may implicate gut‐derived signals in the reactivation of central appetite pathways, providing a basis for investigating strategies to sustain weight loss.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ObesityWeight GainBile Acids and SaltsGastrointestinal MicrobiomeGlucagon-Like PeptidesCentral Nervous SystemFemaleAnimalsSemaglutideHumansRatsProspective StudiesWeight LossHypothalamus

Stichwörter der Autor:innen

GLP‐1RA withdrawalappetite reboundobesityweight regain

Substanzen

SemaglutideBile Acids and SaltsGlucagon-Like Peptides

Autor:innen und Institutionen

  • Department of Endocrinology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Postdoctoral Research Station, School of Nursing, Health Science Center, Xi'an Jiaotong University, Xi'an, China.
  • Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, China.
  • Department of Endocrinology, Xi'an No.3 Hospital, The Affiliated Hospital of Northwest University, Xi'an, China.
  • Department of Endocrinology, 521 Hospital of Norinco Group, Xi'an, China.
  • Department of Respiratory Medicine, Xi'an No.4 Hospital, Xi'an, China.

ORCID-Profile: Bo Sun

Förderung

  • National Natural Science Foundation of China
  • IIT Clinical Research Fund of The Second Affiliated Hospital of Xi'an Jiaotong University
  • Natural Science Basic Research Program of Shaanxi Province
  • Basic and Clinical Integrated Research Program of Xi'an Jiaotong University

Zitieren

APA

Wang, N., Guo, H., Song, L., Wang, J., Hu, S., Wang, M., Zhang, D., Jing, Y., Zhang, Y., Wang, M., Wang, T., & Sun, B. (2026). Post‐semaglutide weight regain in females with obesity: Associations with gut microbiota, bile acid metabolism, and central nervous system. Diabetes, Obesity and Metabolism, 28(5), 3903-3916. https://doi.org/10.1111/dom.70571

Vancouver

Wang N, Guo H, Song L, Wang J, Hu S, Wang M, et al. Post‐semaglutide weight regain in females with obesity: Associations with gut microbiota, bile acid metabolism, and central nervous system. Diabetes, Obesity and Metabolism. 2026;28(5):3903-3916. doi:10.1111/dom.70571

BibTeX
@article{Wang2026,
  author = {Wang, Ning and Guo, Haonan and Song, Lin and Wang, Jingyue and Hu, Shuyuan and Wang, Mingxi and Zhang, Duowen and Jing, Yingyu and Zhang, Yifan and Wang, Mengjun and Wang, Ting and Sun, Bo},
  title = {Post‐semaglutide weight regain in females with obesity: Associations with gut microbiota, bile acid metabolism, and central nervous system},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  volume = {28},
  number = {5},
  pages = {3903--3916},
  doi = {10.1111/dom.70571}
}
Kostenlos starten →